Navigation Links
Zimmer Receives Recognition for Health Economics Data Presented at 77th Annual American Academy of Orthopaedic Surgeons Meeting
Date:3/10/2010

WARSAW, Ind., March 10 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a leader in musculoskeletal care, today announced that presentations by its Global Market Access group were among the highlights of the Company's presence at the 77th annual American Academy of Orthopaedic Surgeons (AAOS) meeting in New Orleans.  

Today's health care environment places growing pressures on surgeons and hospitals to provide care while also exercising fiscal restraint.  Zimmer's presentations provided an opportunity for informed dialogue among orthopaedic physicians and administrators with the goal of better understanding the trends shaping health economics today.

"We see a demonstrated increase in demand for total hip and total knee arthroplasty procedures, and this is expected to continue," said Cheryl R. Blanchard, Ph.D, Senior Vice President and Chief Scientific Officer at Zimmer.  "Zimmer is committed to helping guide our customers through an increasingly expansive and intricate market by providing comprehensive data describing the costs and benefits of orthopaedic surgery."

Total joint replacement is the most frequently performed procedure for advanced osteoarthritis of the hip and knee, yet there is a dearth of research investigating the direct costs, both orthopaedic and non-orthopaedic, for the procedures.  While total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures are widely considered among the most cost effective surgical interventions in the field of medicine, reliable and objective quantification of their economic characteristics has been lacking.  At the AAOS meeting, Zimmer's Global Market Access group presented "Cost of Illness Models for Primary TKA and THA Procedures in the United States," the first comprehensive analysis of the total costs of total joint replacement drawn from both Medicare and commercial payer data.  This podium presentation has been selected as Best in Category by the AAOS committee for Practice Management and Rehabilitation.  

The group also presented "Trends in Commercial Insurance Payments to Hospitals and Physicians for TKA and THA Procedures."  Orthopaedic practices remain significant revenue drivers at hospitals, and this analysis provides comprehensive data which tracks the divergence in reimbursement rates over the past decade.  Both presentations were led by Ryan M. Graver, Director, Global Market Access and Health Economics at Zimmer.  

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2009 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.

Back to top

RELATED LINKS
http://www.zimmer.com

'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
3. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
4. Zimmer Holdings to Present at Upcoming Investor Conferences
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA ... most comprehensive mental health systems reform legislation in more than fifty years. We ... the commitment of our elected officials to improving mental health services and supports ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a simple, ... and tightening the skin of the face to create more youthful features. While ... very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure that ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... a purchase price of approximately $17.4 million (net of the cash acquired), ... approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a leading provider ...
(Date:12/7/2016)... Valley, CA (PRWEB) , ... December 07, 2016 , ... ... be used in several ways to restore a more youthful appearance to the face. ... now offer Sculptra, along with a variety of other treatments, to rejuvenate and renew ...
(Date:12/7/2016)... , ... December 07, 2016 , ... They are musicians ... sisters and wives, brothers and fathers, from New England and around the nation. What ... stigma, and are brought together in a beautiful and compelling new photographic exhibit debuting ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. ... health care products and services to office-based dental, animal health ... percent equity investment in Marrodent, one of Poland,s ... approximately $32 million. This transaction was announced on August 30, ... in Poland since 2014, and Marrodent ...
(Date:12/8/2016)... Research and Markets has announced the addition of ... their offering. ... The report provides separate comprehensive analytics for the ... Rest of World. Annual estimates and forecasts are provided ... provided for these markets. Market data and analytics are derived from primary ...
(Date:12/7/2016)... , Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical ... on 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 ... , Japan , Kenya , ... Germany , China , Slovakia ... 1 & 2 diabetes mellitus. The patent on Lantus expired in 2014. ...
Breaking Medicine Technology: